321 related articles for article (PubMed ID: 19926854)
21. Potential analgesic effects of a novel N-acylethanolamine acid amidase inhibitor F96 through PPAR-α.
Yang L; Li L; Chen L; Li Y; Chen H; Li Y; Ji G; Lin D; Liu Z; Qiu Y
Sci Rep; 2015 Aug; 5():13565. PubMed ID: 26310614
[TBL] [Abstract][Full Text] [Related]
22. Progress in the development of β-lactams as N-Acylethanolamine Acid Amidase (NAAA) inhibitors: Synthesis and SAR study of new, potent N-O-substituted derivatives.
Petracca R; Ponzano S; Bertozzi SM; Sasso O; Piomelli D; Bandiera T; Bertozzi F
Eur J Med Chem; 2017 Jan; 126():561-575. PubMed ID: 27915171
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and biological evaluation of new potential inhibitors of N-acylethanolamine hydrolyzing acid amidase.
Saturnino C; Petrosino S; Ligresti A; Palladino C; De Martino G; Bisogno T; Di Marzo V
Bioorg Med Chem Lett; 2010 Feb; 20(3):1210-3. PubMed ID: 20022504
[TBL] [Abstract][Full Text] [Related]
24. Insights in the mechanism of action and inhibition of N-acylethanolamine acid amidase by means of computational methods.
Lodola A; Rivara S; Mor M
Adv Protein Chem Struct Biol; 2014; 96():219-34. PubMed ID: 25443959
[TBL] [Abstract][Full Text] [Related]
25. Synergic Therapeutic Potential of PEA-Um Treatment and NAAA Enzyme Silencing In the Management of Neuroinflammation.
Casili G; Lanza M; Campolo M; Siracusa R; Paterniti I; Ardizzone A; Scuderi SA; Cuzzocrea S; Esposito E
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050589
[TBL] [Abstract][Full Text] [Related]
26. An Important Role for N-Acylethanolamine Acid Amidase in the Complete Freund's Adjuvant Rat Model of Arthritis.
Bonezzi FT; Sasso O; Pontis S; Realini N; Romeo E; Ponzano S; Nuzzi A; Fiasella A; Bertozzi F; Piomelli D
J Pharmacol Exp Ther; 2016 Mar; 356(3):656-63. PubMed ID: 26769918
[TBL] [Abstract][Full Text] [Related]
27. Second-Generation Non-Covalent NAAA Inhibitors are Protective in a Model of Multiple Sclerosis.
Migliore M; Pontis S; Fuentes de Arriba AL; Realini N; Torrente E; Armirotti A; Romeo E; Di Martino S; Russo D; Pizzirani D; Summa M; Lanfranco M; Ottonello G; Busquet P; Jung KM; Garcia-Guzman M; Heim R; Scarpelli R; Piomelli D
Angew Chem Int Ed Engl; 2016 Sep; 55(37):11193-11197. PubMed ID: 27404798
[TBL] [Abstract][Full Text] [Related]
28. N-acylethanolamine-hydrolysing acid amidase: A new potential target to treat paclitaxel-induced neuropathy.
Toma W; Caillaud M; Patel NH; Tran TH; Donvito G; Roberts J; Bagdas D; Jackson A; Lichtman A; Gewirtz DA; Makriyannis A; Malamas MS; Imad Damaj M
Eur J Pain; 2021 Jul; 25(6):1367-1380. PubMed ID: 33675555
[TBL] [Abstract][Full Text] [Related]
29. Assay of NAAA Activity.
Tsuboi K; Ueda N
Methods Mol Biol; 2023; 2576():261-274. PubMed ID: 36152194
[TBL] [Abstract][Full Text] [Related]
30. N-Acylethanolamine Acid Amidase contributes to disease progression in a mouse model of multiple sclerosis.
Pontis S; Palese F; Summa M; Realini N; Lanfranco M; De Mei C; Piomelli D
Pharmacol Res; 2020 Oct; 160():105064. PubMed ID: 32634582
[TBL] [Abstract][Full Text] [Related]
31. Acute intracerebroventricular administration of palmitoylethanolamide, an endogenous peroxisome proliferator-activated receptor-alpha agonist, modulates carrageenan-induced paw edema in mice.
D'Agostino G; La Rana G; Russo R; Sasso O; Iacono A; Esposito E; Raso GM; Cuzzocrea S; Lo Verme J; Piomelli D; Meli R; Calignano A
J Pharmacol Exp Ther; 2007 Sep; 322(3):1137-43. PubMed ID: 17565008
[TBL] [Abstract][Full Text] [Related]
32. Molecular mechanism of activation of the immunoregulatory amidase NAAA.
Gorelik A; Gebai A; Illes K; Piomelli D; Nagar B
Proc Natl Acad Sci U S A; 2018 Oct; 115(43):E10032-E10040. PubMed ID: 30301806
[TBL] [Abstract][Full Text] [Related]
33. Palmitoylethanolamide (PEA) reduces postoperative adhesions after experimental strabismus surgery in rabbits by suppressing canonical and non-canonical TGFβ signaling through PPARα.
Li Y; Zhao S; Xu S; Li Y; Wang C; Ren J; Li F; Hu X; Lin K; Qiu Y; Xiu Y
Biochem Pharmacol; 2021 Feb; 184():114398. PubMed ID: 33385371
[TBL] [Abstract][Full Text] [Related]
34. N-Acylethanolamine-Hydrolyzing Acid Amidase Inhibition, but Not Fatty Acid Amide Hydrolase Inhibition, Prevents the Development of Experimental Autoimmune Encephalomyelitis in Mice.
Bottemanne P; Guillemot-Legris O; Paquot A; Masquelier J; Malamas M; Makriyannis A; Alhouayek M; Muccioli GG
Neurotherapeutics; 2021 Jul; 18(3):1815-1833. PubMed ID: 34235639
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and structure-activity relationship (SAR) of 2-methyl-4-oxo-3-oxetanylcarbamic acid esters, a class of potent N-acylethanolamine acid amidase (NAAA) inhibitors.
Ponzano S; Bertozzi F; Mengatto L; Dionisi M; Armirotti A; Romeo E; Berteotti A; Fiorelli C; Tarozzo G; Reggiani A; Duranti A; Tarzia G; Mor M; Cavalli A; Piomelli D; Bandiera T
J Med Chem; 2013 Sep; 56(17):6917-34. PubMed ID: 23991897
[TBL] [Abstract][Full Text] [Related]
36. Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages.
Sun YX; Tsuboi K; Zhao LY; Okamoto Y; Lambert DM; Ueda N
Biochim Biophys Acta; 2005 Oct; 1736(3):211-20. PubMed ID: 16154384
[TBL] [Abstract][Full Text] [Related]
37. N-acylethanolamine acid amidase (NAAA), a new path to unleash PPAR-mediated analgesia.
Taylor BK
Pain; 2013 Mar; 154(3):326-327. PubMed ID: 23333052
[No Abstract] [Full Text] [Related]
38. Mass spectrometric characterization of human N-acylethanolamine-hydrolyzing acid amidase.
West JM; Zvonok N; Whitten KM; Wood JT; Makriyannis A
J Proteome Res; 2012 Feb; 11(2):972-81. PubMed ID: 22040171
[TBL] [Abstract][Full Text] [Related]
39. Adelmidrol increases the endogenous concentrations of palmitoylethanolamide in canine keratinocytes and down-regulates an inflammatory reaction in an in vitro model of contact allergic dermatitis.
Petrosino S; Puigdemont A; Della Valle MF; Fusco M; Verde R; Allarà M; Aveta T; Orlando P; Di Marzo V
Vet J; 2016 Jan; 207():85-91. PubMed ID: 26639824
[TBL] [Abstract][Full Text] [Related]
40. Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptors.
Melis M; Pillolla G; Luchicchi A; Muntoni AL; Yasar S; Goldberg SR; Pistis M
J Neurosci; 2008 Dec; 28(51):13985-94. PubMed ID: 19091987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
